M.D.C. Holdings, Inc. (MDC) to Issue Quarterly Dividend of $0.30 on November 27th

M.D.C. Holdings, Inc. (NYSE:MDC) announced a quarterly dividend on Monday, October 28th, Zacks reports. Investors of record on Wednesday, November 13th will be given a dividend of 0.30 per share by the construction company on Wednesday, November 27th. This represents a $1.20 dividend on an annualized basis and a yield of 3.20%. The ex-dividend date is Tuesday, November 12th.

M.D.C. stock opened at $37.55 on Friday. The firm’s 50 day simple moving average is $42.86 and its 200 day simple moving average is $36.86. The company has a current ratio of 9.08, a quick ratio of 1.83 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $2.35 billion, a PE ratio of 10.23, a price-to-earnings-growth ratio of 1.04 and a beta of 1.04. M.D.C. has a 1-year low of $25.77 and a 1-year high of $46.84.

M.D.C. (NYSE:MDC) last posted its earnings results on Wednesday, October 30th. The construction company reported $0.79 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.87 by ($0.08). The firm had revenue of $750.27 million for the quarter, compared to the consensus estimate of $767.23 million. M.D.C. had a return on equity of 12.73% and a net margin of 6.58%. The business’s revenue was down 2.1% on a year-over-year basis. During the same period last year, the company posted $0.86 EPS. Research analysts forecast that M.D.C. will post 3.54 earnings per share for the current year.

MDC has been the topic of a number of analyst reports. Cfra raised shares of M.D.C. from a “hold” rating to a “buy” rating in a report on Thursday, October 31st. Zelman & Associates lowered shares of M.D.C. from a “buy” rating to a “hold” rating in a report on Thursday, October 31st. Raymond James raised shares of M.D.C. from an “outperform” rating to a “strong-buy” rating and upped their target price for the stock from $42.00 to $49.00 in a report on Friday, September 13th. Wedbush upped their target price on shares of M.D.C. from $35.00 to $41.00 and gave the stock a “neutral” rating in a report on Friday, September 13th. Finally, ValuEngine lowered shares of M.D.C. from a “hold” rating to a “sell” rating in a report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have issued a hold rating, one has assigned a buy rating and two have given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $44.00.

In other news, Director David Siegel sold 23,523 shares of the stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $36.83, for a total value of $866,352.09. Following the transaction, the director now owns 45,273 shares of the company’s stock, valued at approximately $1,667,404.59. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Jean-Frederic Viret sold 3,159 shares of the stock in a transaction on Wednesday, September 18th. The stock was sold at an average price of $20.44, for a total transaction of $64,569.96. Insiders sold a total of 98,832 shares of company stock worth $4,248,023 in the last three months. Insiders own 26.30% of the company’s stock.

About M.D.C.

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

Featured Article: What are retained earnings?

Dividend History for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.